Language
Germany

Initial notification · 14.08.2026

Supply shortage: Tarka 240 mg/4 mg Tabletten mit veränderter Wirkstofffreisetzung

Affected country: Germany · Reported period: 06.08.2026 – 16.11.2026 · Active ingredient: Trandolapril; Verapamilhydrochlorid

CountryGermany
PZN03359486
ENR2165603
Notification typeInitial notification
Start06.08.2026
Expected end16.11.2026
Last update14.08.2026
ReasonOther
ATCC09BB10
Hospital-relevantNo

Notice context

A supply shortage has been recorded for Tarka 240 mg/4 mg Tabletten mit veränderter Wirkstofffreisetzung in Germany. The stated reason is “Other”. The notice concerns the active ingredient Trandolapril; Verapamilhydrochlorid and is not identified as hospital-relevant.

This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.

Primary source: PharmNet.Bund / BfArM

Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.

Check the official notice list →

SEO-relevant topics